- Country: India
Latest coverage
- Country: India
GLP-1 medicine use without expert advice dangerous: Doctors
- Press releases
- Country: United States
Why PureHealth Research Formulates Its GLP-1 Support Supplements with Prebiotic Fiber and Electrolytes?
MANASSAS, Va., Oct. 3, 2026 /PRNewswire/ -- As GLP-1 medications reshape how millions of people eat, a quieter question is getting far less attention: what happens to nutrition when appetite drops sharply? PureHealth Research is addressing that gap directly, with a collection built around...
- Tabloid newspaper
- Country: United States
GLP-1 use is way up in a key demographic — rates are 24x higher than in 2018
Despite many other benefits that have emerged, people are mainly on it to shed pounds — including one demographic in particular, whose use of the drug has skyrocketed from .8% in 2018 to 1.9% in 2025 — a 24-fold increase.
- Country: United States
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.